Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

Over the last decades, billions have been spent and huge efforts have been taken in basic and clinical cancer research [CA Cancer J Clin 63: 11-30]. About a decade ago, the arms race between drugs and cancer cells reached a new level by introduction of tyrosine kinase inhibitors (TKI) into pharmacol...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Eckstein, Niels, Röper, Lea, Haas, Bodo, Potthast, Henrike, Hermes, Ulrike, Unkrig, Christoph, Naumann-Winter, Frauke, Enzmann, Harald
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2014
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3922331/
https://ncbi.nlm.nih.gov/pubmed/24502453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-33-15
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker